A 12-month, Open Label, Multicenter Pilot Study Evaluating Fingolimod Treatment in terms of Patient Satisfaction in Relapsing Remitting Multiple Sclerosis Patients FINE Trial

Akman Demir, Gulsen; Turkoglu, Recai; Saip, Sabahattin; Yuceyar, Nur; EFENDİ, HÜSNÜ; TURAN, ÖMER; AĞAN YILDIRIM, KADRİYE; TERZİ, MURAT; BOZ, CAVİT; Tuncer, Asli; Kocer, Belgin; Kasap, Mithat; Caliskan, Zeynep

doi:10.5152/npa.2017.20515

A 12-month, Open Label, Multicenter Pilot Study Evaluating Fingolimod Treatment in terms of Patient Satisfaction in Relapsing Remitting Multiple Sclerosis Patients FINE Trial

Akman Demir G., Turkoglu R., Saip S., Yuceyar N., EFENDİ H. , TURAN Ö. F. , ...More

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, vol.56, no.4, pp.253-257, 2019 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 56 Issue: 4
Publication Date: 2019
Doi Number: 10.5152/npa.2017.20515
Title of Journal : NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
Page Numbers: pp.253-257

Abstract

Introduction: To assess satisfaction and quality of life in patients with relapsing-remitting multiple sclerosis (RRMS) who were receiving fingolimod (0.5 mg/day) for 12 months as a second-line treatment after switching from injectable agents.